A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men

Conclusions. The Towne/Toledo chimera vaccine candidates were well tolerated and were not excreted. Additional human trials of chimeras 2 and 4 are appropriate.
Clinical Trials Registration. NCT01195571.

Source: The Journal of Infectious Diseases - October 12, 2016 Category: Infectious Diseases Authors: Adler, S. P., Manganello, A.-M., Lee, R., McVoy, M. A., Nixon, D. E., Plotkin, S., Mocarski, E., Cox, J. H., Fast, P. E., Nesterenko, P. A., Murray, S. E., Hill, A. B., Kemble, G. Tags: VIRUSES Source Type: research